Home
The Department of Biomedicine

News archive for The Department of Biomedicine

UiB researchers are behind a new discovery that tells us how associated neurodegenerative diseases might develop.
CNPase is an enzyme present at high levels in myelinating cells. Novel nanobody tools developed in an international collaboration were used to identify binding epitopes at atomic resolution and visualise myelin. Additionally, the nanobodies were used as intrabodies to bind to CNPase in living cells. These nanotools will be valuable for future research on myelin and its molecules.
Oxygen is vital for human life and so is our ability to respond to low oxygen levels. Researchers at the University of Oxford and University of Bergen have uncovered new factors defining how human cells respond to hypoxia.
Congratulation to José Miguel Godoy who won the prizes for best 3-min presentation at the Biocat conference last week.
TargetRNA is an EU Horizon funded Marie Skłodowska-Curie Action (MSCA) doctoral training network. In this network, 16 PhD students will be trained in RNA-ligand design in the context of antimicrobial drug discovery.
New PhD using deep learning to analyse multiparametric MRI images to grade and track tumour cell spreading in the brain.
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
BORTEM-17 interim analysis results and small molecule inhibitor targeting CSPG4/NG2 in glioblastoma at American Association for Cancer Research (AACR 2024) April 5-10, 2024
It was a great privilege to participate at ‘AACR Annual Meeting 2024’, a large and important conference for cancer research, the place where scientists, clinicians, survivors, and patients, gather to share and discuss the latest breakthroughs.
Tore Ivar Malmei Aarsland will defend his PhD degree at the University of Bergen on 21 May 2024 with the thesis "Tryptophan and kynurenine pathway metabolites in neuropsychiatric disorders".
Brain calcification can cause movement disorders and cognitive impairment. New research by the Arnesen Lab at UiB provides increased insight into how these calcifications occur.
Congratulations to Peter on becoming a PhD holder!
Peter Daniel Szigetvari will defend his PhD degree at the University of Bergen on 14 February 2024 with the thesis "Monoamine synthesis in neurometabolic disorders affecting catecholaminergic functioning".
The Brenk lab has published an article in which they have investigated the presence of metal-coordinating groups in screening libraries and chemical spaces. This can help with the discovery for new inhibitors for metallo enzymes.
Researchers from the University of Bergen (UiB) have uncovered that proteins use a common chemical label as a shield to protect them from degradation, which in turn affects motility and aging.
Research advisors at the Faculty of Medicine have recently launched a new portal for researchers applying for external funding.

Pages